NCT07096778
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07096778
Title Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma (DoMMino-1)
Acronym DoMMino-1
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors CellCentric Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR


No variant requirements are available.